Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Equity Ratio (2016 - 2026)

Avanos Medical's Equity Ratio history spans 13 years, with the latest figure at 0.72 for Q4 2025.

  • On a quarterly basis, Equity Ratio rose 0.97% to 0.72 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.72, a 0.97% increase, with the full-year FY2025 number at 0.72, up 0.97% from a year prior.
  • Equity Ratio hit 0.72 in Q4 2025 for Avanos Medical, down from 0.73 in the prior quarter.
  • Over the last five years, Equity Ratio for AVNS hit a ceiling of 1.01 in Q2 2024 and a floor of 0.75 in Q2 2025.
  • Historically, Equity Ratio has averaged 0.51 across 5 years, with a median of 0.73 in 2025.
  • Biggest five-year swings in Equity Ratio: surged 14859.15% in 2021 and later tumbled 1005.63% in 2025.
  • Tracing AVNS's Equity Ratio over 5 years: stood at 0.79 in 2021, then fell by 8.8% to 0.72 in 2022, then grew by 1.09% to 0.73 in 2023, then decreased by 1.74% to 0.72 in 2024, then rose by 0.97% to 0.72 in 2025.
  • Business Quant data shows Equity Ratio for AVNS at 0.72 in Q4 2025, 0.73 in Q3 2025, and 0.75 in Q2 2025.